Premium
Double‐blind study of the analgesic effect of indoprofen (K 4277)
Author(s) -
Fuccella Luciano M.,
Conti Franco,
Corvi Giulio,
Mandelli Virginio,
Randelli Mario,
Stefanelli Giuseppe
Publication year - 1975
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1975173277
Subject(s) - medicine , placebo , anesthesia , crossover study , analgesic , double blind , cancer pain , cancer , alternative medicine , pathology
In a double‐blind study, indoprofen was superior to placebo in decreasing pain in patients with primary and metastatic cancer and with neuralgia. A single oral dose of 200 mg was more active than a 100‐mg dose. The preferences of patients proved to be a more sensitive parameter in this study than scores of pain intensity, pain relief, and other related measurements (SPID, TOTPAR, and Peak PID).